Showing results (1821-1830 of 3,668) with videos related to

Sort By:
Pageof 367
American Journal of Epidemiology|September 14, 2011
Body size across the life course, mammographic density, and risk of breast cancerHolly R Harris, Rulla M Tamimi, Walter C Willett, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Validating fiducial markers for image-guided radiation therapy for accelerated partial breast irradiation in early-stage breast cancerCatherine K Park, Jakub Pritz, Geoffrey G Zhang, et al.
Preventing Chronic Disease|April 7, 2012
Increasing evidence-based workplace health promotion best practices in small and low-wage companies, Mason County, Washington, 2009Sharon S Laing, Peggy A Hannon, Amber Talburt, et al.
BMJ Health & Care Informatics|September 28, 2021
Influence of social determinants of health and county vaccination rates on machine learning models to predict COVID-19 case growth in TennesseeLukasz S Wylezinski, Coleman R Harris, Cody N Heiser, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|May 3, 2019
Provider-Patient Communication and Involvement in Physical Activity Programs Among Patients Receiving Physical Therapy Services: A Qualitative StudyChristine M Kava, Sarah Fishleder, Lesley Steinman, et al.
Journal of Agricultural Safety and Health|February 24, 2001
Finite element modeling of ROPS in static testing and rear overturnsJ R Harris, V H Mucino, J R Etherton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1984
Antigen presentation by the BCL1 murine B cell line: in vitro stimulation by LPSM R Harris, C S Kindle, A F Abruzzini, et al.
Diabetologia|July 1, 1984
HLA antigens and risk factors for nephropathy in type 1 (insulin-dependent) diabetes mellitusC Walton, P A Dyer, J A Davidson, et al.
International Journal of Immunopharmacology|February 1, 1995
Clinical activity of leukotriene inhibitorsR R Harris, G W Carter, R L Bell, et al.
The Journal of Laryngology and Otology|May 1, 1993
Type 2 neurofibromatosis: the need for supraregional care?D G Evans, R Ramsden, S M Huson, et al.
Pageof 367